IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets.
| Revenue (TTM) | $4.45B |
| Gross Profit (TTM) | $2.76B |
| EBITDA | $1.55B |
| Operating Margin | 31.80% |
| Return on Equity | 72.90% |
| Return on Assets | 26.50% |
| Revenue/Share (TTM) | $55.57 |
| Book Value | $19.64 |
| Price-to-Book | 28.28 |
| Price-to-Sales (TTM) | 9.86 |
| EV/Revenue | 10.1 |
| EV/EBITDA | 28.84 |
| Quarterly Earnings Growth (YoY) | 17.20% |
| Quarterly Revenue Growth (YoY) | 14.30% |
| Shares Outstanding | $78.88M |
| Float | $78.58M |
| % Insiders | 0.22% |
| % Institutions | 96.00% |
Volatility is currently contracting
Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 second quarter financial results for Tuesday, August 4, 2026, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2026 Earnings Snapshot through a link on the IDEXX websi.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Investors need to pay close attention to IDXX stock based on the movements in the options market lately.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
IDEXX Laboratories, Inc. (IDXX) Presents at Stifel Jaws & Paws Conference 2026 Transcript
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX integrates SDMA into most common Catalyst chemistry profiles, enabling earlier detection of kidney disease through routine in‑clinic testing.
WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 27, 2026 from 10:55 am – 11:25 am (ET). A live audio webcast of the presentation will be available through a link on the IDEXX website, www.idexx.com/investors. An archived edition of the presentation will b.
